TrialJAMA oncology2022

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial.

Neal D Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.